A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients.

The primary manifestation of the antiphospholipid antibody syndrome (APS) is thrombosis, which forms the core of the classification criteria for this syndrome. However, multiple other noncriteria ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Discover the crucial link between antiphospholipid syndrome and pregnancy outcomes to improve diagnosis, treatment, and ...

Please provide your email address to receive an email when new articles are posted on . The presence of antiphospholipid antibodies independently predicted future atherosclerotic cardiovascular ...

“There are a lot of unanswered questions about how APS affects pediatric patients since evidence to date has been very limited,” said Jheel Pandya, MD, a pediatric rheumatology fellow at HSS and lead ...

The presence of antiphospholipid antibodies is associated with an increased risk for future cardiovascular events, according to a new study. The findings point to possible new approaches to risk ...

Blood-clot-promoting autoantibodies have been found in at least half of the serum samples collected from 172 patients hospitalized with COVID-19. These autoantibodies—which are also linked to a ...

Asherson’s syndrome, also known as catastrophic antiphospholipid syndrome (CAPS), is an extremely rare autoimmune condition. It is defined by the fast progression of blood clots impacting many organ ...

A male in his 50s presented to the renal department with a diagnostic challenge of an unexplained kidney injury.